아스파라기나제 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00008224
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 176
Buy Now

아스파라기나제 시장은 2021년 5억 6,401만 달러에서 2028년 15억 7,562만 달러로 성장할 것으로 예상됩니다. 2022년부터 2028년까지 연평균 성장률(CAGR) 16.1%로 성장할 것으로 예상됩니다. 

아스파라기나아제는 아스파라긴을 분해하는 효소입니다. 아스파라기나아제는 급성 림프구성 백혈병(ALL), 림프구성 림프종(LBL) 및 특정 기타 혈액암을 치료하기 위한 화학요법 약물로 사용됩니다. 정상 세포와 달리 ALL 세포는 아스파라긴을 만들 수 없습니다. 따라서 아스파라기나아제는 암세포의 분열과 성장을 막습니다. 아스파라기나제는 대장균(Escherichia coli), 에르위니아 크리산테미(Erwinia chrysanthemi), 페길화 아스파라기나제, 곰팡이, 조류 등에서 추출됩니다.

전 세계 아스파라기나제 시장은 유형, 응용 분야, 최종 사용 산업 및 지역을 기준으로 분류됩니다. 지역별로 시장은 북미, 유럽, 아시아 태평양, 중동 및 지역으로 크게 분류됩니다. 아프리카, 남부 & 중앙 아메리카. 이 보고서는 시장 동향, 역학 등의 매개변수와 전 세계 선두 시장 플레이어의 경쟁 분석을 강조하면서 시장에 대한 통찰력과 심층 분석을 제공합니다.

전략적 통찰력

글로벌 아스파라기나제 시장의 수익성이 높은 지역

시장 통찰력

제약 및 식품 산업의 상당한 성장으로 글로벌 아스파라기나제 시장이 성장하고 있습니다

제약 및 식품 산업 식품 산업은 식품 및 의약품의 높은 품질을 보장하기 위해 크게 발전했으며 다양한 발전을 관찰했습니다. 유럽제약산업협회에 따르면 북미 지역은 2021년 전 세계 의약품 매출의 49%를 차지했고, 2015년부터 2020년까지 새로 출시된 의약품에서 창출된 매출의 63.7%를 차지했다. 더욱이 제약산업은 상당한 속도로 발전하고 있다. , R&D 활동의 급증, 시장 참가자들의 제약 산업에 대한 투자 증가에 힘입어 시장을 더욱 주도하고 있습니다.

식품 산업은 끝없는 식품 증가와 함께 지속적으로 확장되고 있습니다. 수요. 새로운 식품도 지속적으로 증가하고 있습니다. 요즘 제조업체들은 식품의 영양적 양에 중점을 두고 있습니다. 전 세계적으로 튀김이나 구운 음식의 소비가 크게 늘었고, 그러한 음식에 대한 선호도도 급증했습니다. 아스파라기나아제는 카르보닐 공급원이 응축된 튀김 및 구운 음식에서 설탕을 줄이는 역할을 하는 주요 아미노산입니다.

유형 분석

유형에 따라 전 세계 아스파라기나아제 시장은 대장균으로 분류됩니다. (E. coli), Erwina Chrysanthemi, Pegylated 등이 있습니다. 대장균 부문은 2021년 시장에서 더 큰 점유율을 차지했으며, 이 부문은 대장균에서 추출된 아스파라기나제에 대한 수요 증가로 인해 2022~2028년 예측 기간 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. ALL 및 LBL과 같은 암 치료.

아스파라기나제 유래 대장균은 급성 림프구성 백혈병 치료에 사용됩니다. 아스파라기나제 대장균(Asparaginase E. coli)은 L-아스파라긴을 L-아스파라긴산과 암모니아로 촉매작용시키는 효소입니다. 세포 대사에 필요한 옥살로아세트산 생성을 돕습니다. 대장균의 아스파라기나제는 백혈병 치료에 사용되는 항종양 특성을 가지고 있습니다. 따라서 특히 소아 환자의 암 치료를 위한 아스파라기나제 대장균에 대한 수요가 시장 성장을 주도하고 있습니다.

유형별 글로벌 아스파라기나제 시장 – 2021년 및 2028년

Application Insights

응용 프로그램을 기반으로 글로벌 아스파라기나제 시장은 치료, 식품 가공 등으로 나누어집니다. 치료 부문은 2021년 시장에서 더 큰 점유율을 차지했으며, 이 부문은 림프증식성 질환 및 림프종 치료에 사용되기 때문에 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. 이 세그먼트는 급성 림프구성 백혈병, 림프구성 림프종 등으로 더 세분화됩니다.

급성 림프구성 백혈병은 혈액암과 골수의 일종으로, 치료하지 않으면 치명적입니다. 보건계량평가연구소(Institute for Health Metrics and Evaluation)에 따르면, 2019년 전 세계적으로 약 153,000명의 급성 림프모구 백혈병 신규 사례와 47,600명의 사망이 보고되었습니다. 따라서 전 세계적으로 급성 림프모구 백혈병 사례의 증가가 글로벌 아스파라기나제 시장의 성장을 주도하고 있습니다.

< h3>최종 용도 산업 통찰

최종 용도를 기준으로 글로벌 아스파라기나제 시장은 의료 및 식품 제조로 분류됩니다. 헬스케어 부문은 2021년 시장에서 더 큰 점유율을 차지했습니다. 또한 동일한 부문은 2022년부터 2028년까지 가장 높은 CAGR을 기록할 것으로 예상됩니다. 이 부문 성장의 원동력은 급성 림프구성 백혈병, 림프구성 림프종의 증가 및 연구 증가입니다. 활동.

시장에서 목격된 무기적 성장 전략은 인수합병, 파트너십, 협업이었다. 이러한 활동은 비즈니스 확장과 시장 참가자의 고객 기반을 위한 기반을 마련했습니다. 최근 주요 시장 발전 중 일부는 다음과 같습니다.

  • 2021년 5월 Jazz Pharmaceuticals는 GW 제약 회사를 인수하여 R&D 역량을 강화합니다. 이번 인수는 또한 회사가 칸나비노이드 기반 처방약을 개발하고 상업화하는 데 도움이 될 것입니다.
  • 2021년 4월 Servier는 Agios Pharmaceuticals’ 상업, 임상 및 연구 단계 종양학 포트폴리오를 포함하여 20억 달러 이상의 로열티. 이번 인수로 미국 악성 혈액학 시장에서 Servier의 상업적 입지가 강화되고 고형 종양 분야에서 장기적인 성장 가능성이 제공됩니다.
  • 2018년 8월, Medac GmBH는 FarmaMondo SA와 협력하여 러시아, 조지아, 아제르바이잔, 키르기스스탄, 우즈베키스탄 및 몰도바의 대상 의료 서비스 제공자를 위한 관리형 액세스 프로그램을 통해 Spectrila를 독점 배포할 예정입니다. FarmaMondo는 급성 림프구성 백혈병 환자를 위해 Spectrila에 대한 액세스를 관리할 것입니다.

글로벌 아스파라기나제 시장에서 활동하는 주요 업체로는 Servier Pharmaceuticals LLC, BioVendor R&D, Creative Enzymes, medac GmbH가 있습니다. , Changzhou Qianhong Bio-pharma Co Ltd, United Biotech, Porton Biopharma, Taj Pharmaceuticals Limited 및 Jazz Pharmaceuticals plc.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are Asparaginase?

Asparaginase is an enzyme that breaks down asparagine. Asparaginase is used as a chemotherapy drug to treat acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LBL), and certain other blood cancers. Unlike normal cells, ALL cells are unable to make their own asparagine. Therefore, asparaginase stops the cancer cells from dividing and growing. Asparaginase are derived from Escherichia coli, Erwinia chrysanthemi, pegylated asparaginase, fungi, algae and others.

What are the driving factors for the global asparaginase market across the world?

The factors that are driving the growth of the asparaginase market are rising incidences of leukemia and increasing usage applications and significant growth of the pharmaceutical and food industry are the major factors contributing to the growth of the asparaginase industry.

Who are the major players in the asparaginase market across the globe?

The asparaginase market majorly consists of the players, such as Servier Pharmaceuticals LLC, Jazz Pharmaceuticals plc, BioVendor R&D, Creative Enzymes, medac GmbH, Changzhou Qianhong Bio-pharma Co Ltd, United Biotech, Porton Biopharma, and Taj Pharmaceuticals Limited and among others.

What is the market CAGR value of the asparaginase market during the forecast period?

The CAGR value of the asparaginase market during the forecasted period of 2022-2028 is 16.1%

What is the estimated asparaginase market size in 2021?

The asparaginase market is estimated to be valued at US$ 564.01 million in 2021.

What are the growth estimates for the asparaginase market till 2028?

The asparaginase market is expected to be valued at US$ 1,575.62 million in 2028.

Which segment by type led the asparaginase market?

The Escherichia Coli segment held the largest share of the market in the global asparaginase market contributing a market share of 49.78% in 2021.

Which region is projected to be the fastest-growing region in the global asparaginase market?

The Asia Pacific is expected to be the fastest-growing region in the asparaginase market over the forecast period due to increasing prevalence of acute lymphoblastic leukemia, increasing research activities in cancer, and increasing innovative products for treatment of hematological cancers by the market players in the region.

The List of Companies - Asparaginase Market

  1. Servier Pharmaceuticals LLC
  2. Jazz Pharmaceuticals plc
  3. BioVendor R&D
  4. Creative Enzymes
  5. medac GmbH
  6. Changzhou Qianhong Bio-pharma Co Ltd
  7. United Biotech
  8. Porton Biopharma
  9. Taj Pharmaceuticals Limited

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports